Home » Products » Pharmaceutical Drugs » Geftinat 250mg Gefitinib Tablets

Geftinat 250mg Gefitinib Tablets

Geftinat 250mg Gefitinib Tablets
Geftinat 250mg Gefitinib Tablets
Send Inquiry
Product Code : 00208
Price And Quantity
  • Minimum Order Quantity
  • 10000000
  • Unit of Measure
  • Piece/Pieces
  • Price
  • 3200/Bottle INR
Product Specifications
  • Drug Type
  • Specific Drug
  • Physical Form
  • Tablets
  • Dosage
  • 250 mg
  • Suitable For
  • Adults, Women
Product Description
 Geftinat - IRESSA® (Geftinat tablets) contain 250 mg of Geftinat and are available as brown film-coated tablets for daily oral administration. IRESSA is indicated as monotherapy for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies. The effectiveness of IRESSA is based on objective response rates (see CLINICAL PHARMACOLOGY — Clinical Studies section). There are no controlled trials demonstrating a clinical benefit, such as improvement in disease-related symptoms or increased survival. Results from two large, controlled, randomized trials in first-line treatment of non-small cell lung cancer showed no benefit from adding IRESSA to doublet, platinum-based chemotherapy. Therefore, IRESSA is not indicated for use in this setting. Active ingredients: Gefitinib
Trade Information
  • Payment Terms
  • Cash in Advance (CID), Cash Advance (CA)
  • Supply Ability
  • 10000000 Per Week
  • Delivery Time
  • 1 Week
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

DHEER HEALTHCARE PRIVATE LIMITED
X


DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.